Study of a PET imaging agent in healthy people and people with cancer
Part of Cancer clinical trials.
This study uses a special imaging agent (a radioactive tracer) to see how it works in healthy volunteers and in people with cancer. It may help doctors better understand how cancer behaves and how to target it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer (any type, confirmed by a scan or biopsy) and have not had any cancer treatment yet, or your cancer has gotten worse on standard treatment.
- You have at least one tumor that is at least 1.5 centimeters (about the size of a pea).
- You are not currently on cancer treatment (including between cycles).
- You do not have certain heart rhythm problems or risk factors for them (like heart failure, low potassium, or family history of Long QT Syndrome).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new PET scan tracer that aims to highlight cancer cells more clearly. If you join, you'll receive one injection of the tracer and then have a PET/CT scan to help your doctor see whether you have cancer or where it is.
This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.
This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.